Stocks of the Hour: ResMed, Ramsay Health Care & Reliance Worldwide

Company News

by Lauren Evans

ResMed (ASX:RMD) increased its revenue by 12 per cent during the March quarter, driven by strong demand in its sleep and respiratory care segment. However, its gross margin decreased by 140 basis points mainly due to higher freight and manufacturing costs, partially offset by favourable product changes and increased selling prices. Shares are trading 6.3 per cent lower at $28.48.

Ramsay Health Care (ASX:RHC) posted a 59 per cent drop in profit after tax during the March quarter as Covid-related issues and higher operating costs continued to impact the healthcare system. However, its revenue lifted 5.7 per cent during the quarter as activity levels started to improve after elective surgery restrictions were lifted in Australia. Shares are trading 0.7 per cent lower at $81.01.

Meanwhile, Reliance Worldwide (ASX:RWC) reported a 14 per cent increase in sales during the nine months to March 31 after it increased prices in all regions to offset cost pressures. However, its adjusted EBITDA fell 4 per cent from the prior year period as the company dealt with higher inflation, particularly in copper and steel, as well as shipping pressures and rising energy costs. Shares are trading 1.3 per cent higher at $4.06.
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.